Sibold William (Director) plans to sell 5,221 MDGL shares, about $2.8M
- Form
- 144
- Filed
- Importance
- Routine
- Accession
- 0001950047-26-009360
- Approximate sale date: Sep 11, 2026
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Shares acquired by: Restricted Stock Units
- 10b5-1 plan adopted: Jun 5, 2026
All of Sibold William's insider filings, holdings and planned sales
Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):
- Sold 131 shares at $527.88 on Sep 9, 2026 · Form 4
- Sold 347 shares at $529.27 on Sep 9, 2026 · Form 4
- Sold 522 shares at $530.23 on Sep 9, 2026 · Form 4
- Sold 368 shares at $531.99 on Sep 9, 2026 · Form 4
- Sold 512 shares at $533.09 on Sep 9, 2026 · Form 4
- Sold 396 shares at $534.2 on Sep 9, 2026 · Form 4
- Sold 644 shares at $535.27 on Sep 9, 2026 · Form 4
- Sold 1,040 shares at $536.11 on Sep 9, 2026 · Form 4
- Sold 640 shares at $537.17 on Sep 9, 2026 · Form 4
- Sold 520 shares at $538.3 on Sep 9, 2026 · Form 4
- Sold 60 shares at $533.09 on Sep 11, 2026 · Form 4
Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Ionis Pharmaceuticals IONS public float $5.3B, Jun 30, 2025
- Repligen RGEN public float $6.0B, Jun 30, 2025
- Corcept Therapeutics CORT public float $6.1B, Jun 30, 2025
- Jazz Pharmaceuticals JAZZ public float $6.3B, Jun 30, 2025
- Biomarin Pharmaceutical BMRN public float $6.7B, Jun 30, 2025